117 related articles for article (PubMed ID: 8535908)
1. The role of bone marrow transplantation in the management of advanced local disease.
Safah H; Weiner RS
Surg Oncol Clin N Am; 1995 Oct; 4(4):735-49. PubMed ID: 8535908
[TBL] [Abstract][Full Text] [Related]
2. Autologous bone marrow transplantation for advanced breast cancer.
Med Lett Drugs Ther; 1991 May; 33(843):39-40. PubMed ID: 2014014
[No Abstract] [Full Text] [Related]
3. [Combination of high-dose chemotherapy with autologous hematopoietic stem cell transplantation for recurrent and high-risk breast cancer: a pilot study].
Shi Y; Pan F; Han X
Zhonghua Yi Xue Za Zhi; 1999 Dec; 79(12):890-3. PubMed ID: 11715500
[TBL] [Abstract][Full Text] [Related]
4. Federal courts still split on autologous bone marrow transplants.
Margolis RE
Healthspan; 1992 Dec; 9(11):20-2. PubMed ID: 10123554
[No Abstract] [Full Text] [Related]
5. [Consolidation radiotherapy after high-dose chemotherapy and autologous bone marrow transplantation in patients with advanced breast cancer].
Rühl U
Strahlenther Onkol; 2000 Apr; 176(4):196-7. PubMed ID: 10812394
[No Abstract] [Full Text] [Related]
6. Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066.
Peppercorn J; Herndon J; Kornblith AB; Peters W; Ahles T; Vredenburgh J; Schwartz G; Shpall E; Hurd DD; Holland J; Winer E
Cancer; 2005 Oct; 104(8):1580-9. PubMed ID: 16118805
[TBL] [Abstract][Full Text] [Related]
7. ABMT (autologous bone marrow transplantation): a microcosm of the U.S. health care system.
McGivney WT
Physician Exec; 1992; 18(1):45-7. PubMed ID: 10116423
[TBL] [Abstract][Full Text] [Related]
8. Perspectives. Indefinite results in ABMT (autologous bone marrow transplantation) trials add to challenges for practice standards, quality assurance in cancer care.
Cunningham R
Med Health; 1999 Apr; 53(16):suppl 1-4. PubMed ID: 10387749
[No Abstract] [Full Text] [Related]
9. Variations in insurance coverage for autologous bone marrow transplantation for breast cancer.
Krause KJ
N Engl J Med; 1994 Aug; 331(5):329; author reply 330-1. PubMed ID: 8068113
[No Abstract] [Full Text] [Related]
10. Comparative cost analysis of autologous peripheral blood progenitor cell and bone marrow transplantation in pediatric patients with malignancies.
Vicent MG; Madero L; Chamorro L; Madero R; Diaz MA
Haematologica; 2001 Oct; 86(10):1087-94. PubMed ID: 11602415
[TBL] [Abstract][Full Text] [Related]
11. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
Skowronek J; Piotrowski T
Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593
[TBL] [Abstract][Full Text] [Related]
12. Tide turning against autologous bone marrow transplants in federal appellate courts.
Margolis RE
Healthspan; 1993 Jun; 10(6):21-2. PubMed ID: 10127304
[No Abstract] [Full Text] [Related]
13. Variations in insurance coverage for autologous bone marrow transplantation for breast cancer.
Templeton KM
N Engl J Med; 1994 Aug; 331(5):330; author reply 330-1. PubMed ID: 8022451
[No Abstract] [Full Text] [Related]
14. Detection of tumor cells in the bone marrow of stage IV breast cancer patients receiving high-dose chemotherapy: the role of induction chemotherapy.
Vredenburgh JJ; Peters WP; Rosner G; DeSombre K; Johnston WW; Kamel A; Wu K; Bast RC
Bone Marrow Transplant; 1995 Dec; 16(6):815-21. PubMed ID: 8750275
[TBL] [Abstract][Full Text] [Related]
15. Variations in insurance coverage for autologous bone marrow transplantation for breast cancer.
Khanna V
N Engl J Med; 1994 Aug; 331(5):330-1. PubMed ID: 8022453
[No Abstract] [Full Text] [Related]
16. Variations in insurance coverage for autologous bone marrow transplantation for breast cancer.
Erban JK
N Engl J Med; 1994 Aug; 331(5):330; author reply 330-1. PubMed ID: 8022450
[No Abstract] [Full Text] [Related]
17. Patient could not sue insurer for denying coverage.
Mamorsky JD
J Health Care Benefits; 1994; 3(5):60-4. PubMed ID: 10133666
[No Abstract] [Full Text] [Related]
18. [High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy in primary breast cancer. An analysis of a systematic Cochrane review].
Nielsen DL; Svane IM
Ugeskr Laeger; 2004 Nov; 166(46):4148-50. PubMed ID: 15565849
[No Abstract] [Full Text] [Related]
19. Autologous bone marrow support and bone disease in metastatic breast cancer.
Nabholtz JM; al-Tweigeri T; Jacquelin N; Venner PM
Can J Oncol; 1995 Dec; 5 Suppl 1():33-9. PubMed ID: 8853522
[TBL] [Abstract][Full Text] [Related]
20. Variations in insurance coverage for autologous bone marrow transplantation for breast cancer.
Wingard JR
N Engl J Med; 1994 Aug; 331(5):330; author reply 330-1. PubMed ID: 8022452
[No Abstract] [Full Text] [Related]
[Next] [New Search]